2025 Fall Conference | C25 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Date Sunday 11/09/25

Time 07:30 AM - 09:00 AM PDT Add To Calendar

Supported By This program is supported in part by educational grants from Eisai Inc. and Lilly

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Lealani M. Acosta, MD, MPH, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia-related cognitive and behavioral symptoms; learn about the proper utilization of disease-modifying treatments for dementia and their role in clinical practice; and apply principles of behavioral tools and indications for pharmacological management and disease-modifying treatment for dementia by selecting appropriate therapies.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials

Event Timeline
07:30 AM - 07:35 AM PDT	Introduction	Introduction Lealani M. Acosta, MD, MPH, FAAN
07:35 AM - 08:00 AM PDT	Speaker	Non-Pharmacological Management of Dementia Helen Kales, MD
08:00 AM - 08:25 AM PDT	Speaker	Pharmacological Management of Dementia Lealani M. Acosta, MD, MPH, FAAN
08:30 AM - 08:55 AM PDT	Speaker	Disease-Modifying Therapeutics in Dementia Meredith Wicklund, MD, FAAN
08:55 AM - 09:00 AM PDT	Q&A	Q&A for Disease-Modifying Therapeutics in Dementia Meredith Wicklund, MD, FAAN

Faculty Disclosures
Lealani M. Acosta, MD, MPH, FAAN	Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Helen Kales, MD	The institution of Helen Kales, MD has received research support from NIH. The institution of Helen Kales, MD has received research support from SAMHSA.

��ɫ��

��ɫ��